Valerianna K. Amorosa, M.D.
Valerianna K. Amorosa, M.D.
Associate Professor of Clinical Medicine
Department: Medicine
Contact information
Philadelphia Veteran's Administration Medical Center,
Department of Medicine
Philadelphia, PA 19104
Department of Medicine
Philadelphia, PA 19104
Office: 215-823-5800
Education:
B.A. (Molecular Biology Cum Laude)
Princeton University, 1993.
M.D.
Washington University in St. Louis, 1998.
Permanent linkB.A. (Molecular Biology Cum Laude)
Princeton University, 1993.
M.D.
Washington University in St. Louis, 1998.
Description of Research Expertise
Clinical research in HIV, HCV coinfectionDescription of Clinical Expertise
HIV, HIV/HCV coinfectionSelected Publications
Lo Re V 3rd, Teal V, Localio AR, Amorosa VK, Kaplan DE, Gross R. : Adherence to Hepatitis C Virus Therapy in HIV/Hepatitis C-Coinfected Patients AIDS Behav. 17(1): 94-103, Jan 2013.Amorosa VK, Aibana O, Shire N, Dorey-Stein Z, Ferrara T, Gilmore J, Kostman J, Lo Re V: Willingness to Undergo a Repeat Liver Biopsy among HIV/Hepatitis C Virus-Coinfected and Hepatitis C Virus-Monoinfected Patients. Journal of Clinical Gastroenterology. ] (eds.). Epub, Jan 2013.
Lee YJ, Osinusi A, M Kang, T Umbleja, Amorosa VK, Kottilil S, Peters MG: Augmentation of Interferon signaling by Nitazoxanide in HIV HCV Coinfected Patients : Exploratory Analysis from the ACTG5269 trial. Conference on Retroviruses and Opportunistic Infections, March 2013, Atlanta GA. 2013.
Raphael BA, Dorey-Stein ZL, Lott J, Amorosa V, Lo Re V 3rd, Kovarik C. : Low prevalence of necrolytic acral erythema in patients with chronic hepatitis C virus infection. J Am Acad Dermatol. Epub ahead of print, February 2012
Nagler A, Kim B, Gormley R, Chandler L, Han J, Amorosa V, Kovarik C.: A Verrucous Nodule on the Upper Lip: A Case of Coccidioidomycosis in a Non-endemic Region. Cutis in press, 2012.
Amorosa V, Umbleja T, Johnson V, Kang M, Leutkemeyer A, Bardin M, Haas D, Chung R, Yesmin S, Alston-Smith B, Tebas P, Peters M : The addition of Nitazoxanide to peginterferon alfa-2a and ribavirin does not significantly improve sustained virologic response in HCV treatment-naïve genotype 1 HIV-1/HCV co-infected subjects: Results of ACTG 5269. IAS conference, Washington, July 2012 2012.
Lo Re V, Teal V, Localio R, Amorosa V, Kaplan D, Gross R: Adherence to Hepatitis C Virus Therapy in HIV-Infected Patients Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q142, 2012 Notes: Poster presentation.
Hafkin J, Osborn M, Kostman J, Chang KM, Amorosa V, Localio R, Mounzer K, Gross R, Lo Re V. : Incidence and Risk Factors for Incomplete HBV Suppression Among Tenofovir-Treated HIV/HBV-Coinfected Patients Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q-173, 2012 Notes: Poster presentation.
Luetkemeyer A, Umbleja T, Amorosa V, Dayyeh B, Chung RT, Kang M, Bardin M, Haas DW, Tebas P, Peters M: Nitazoxanide (NTZ) may Mitigate the Unfavorable Association between IL28B Genotype and Hepatitis C Virus (HCV) Treatment Response to Pegylated Interferon-based therapy Conference on Retroviruses and Opportunistic Infections, March 4-7, 2012, Seattle, WA Page: Q-143, 2012 Notes: Poster presentation.
Lemonovich T, Hanes K, Lautenbach E, Amorosa V: Combination Therapy with an Aminoglycoside for Staphylococcus aureus Endocarditis and/or Persistent Bacteremia Is Associated with Decreased Rate of Recurrent Bacteremia: a Cohort Study. Infection 39(6): 549-54, December 2011 Notes: Epub 2011 Sep 6.